MedTrace Logo

Clinical Evaluation of the SONA Saliva C-19 Rapid Self-Test for the Detection of COVID-19

NCT05256589 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2023-03-24

No results posted yet for this study

Summary

The Sona Saliva C-19 Rapid Self-Test is a lateral flow assay intended for detection of the SARS-CoV-2 virus. Performance of the Sona Saliva C-19 Rapid Test assay will be assessed by comparison to an RT-PCR reference method.

Conditions

Interventions

DIAGNOSTIC_TEST

Sona Saliva C-19 Rapid Self-test

Rapid Antigen diagnostic device performance comparative to RT-PCR

Sponsors & Collaborators

  • Nova Scotia Health Authority

    collaborator OTHER

  • Sona Nanotech Inc

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-19
Primary Completion
2022-04-26
Completion
2022-05-19

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05256589 on ClinicalTrials.gov